NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Ownership - Who owns Quoin Pharmaceuticals?

Insider buying vs selling

Have Quoin Pharmaceuticals Ltd insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Dennis LangerDirector2025-10-1415,152$8.49
$128.64kBuy

1 of 1

QNRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QNRX insiders and whales buy or sell their stock.

QNRX Shareholders

What type of owners hold Quoin Pharmaceuticals Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Stonepine Capital Management LLC11.14%3,271,100$27.48MInsider
Michael Myers2.05%602,808$5.06MInsider
Denise P. Carter2.05%602,648$5.06MInsider
Gordon Dunn0.51%151,077$1.27MInsider
Anthony James Culverwell0.34%100,317$842.66kInsider
Stonepine Capital Management LLC0.27%78,189$656.79kInstitution
Aberdeen Group PLC0.26%75,000$630.00kInstitution
Aigh Capital Management LLC0.17%49,323$414.31kInstitution
Soleus Capital Management LP0.09%25,000$210.00kInstitution
Simplify Asset Management Inc0.06%17,448$146.56kInstitution

1 of 2

QNRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNRX0.90%16.15%Net Buying
ALLR6.63%13.31%Net Selling
CLRB7.31%79.20%Net BuyingNet Selling
FBLG7.35%12.05%Net BuyingNet Buying
INTS5.63%3.52%Net BuyingNet Buying

Quoin Pharmaceuticals Stock Ownership FAQ

Who owns Quoin Pharmaceuticals?

Quoin Pharmaceuticals (NASDAQ: QNRX) is owned by 0.90% institutional shareholders, 16.15% Quoin Pharmaceuticals insiders, and 82.95% retail investors. Stonepine Capital Management LLC is the largest individual Quoin Pharmaceuticals shareholder, owning 3.27M shares representing 11.14% of the company. Stonepine Capital Management LLC's Quoin Pharmaceuticals shares are currently valued at $29.31M.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.